Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixiaro Booster Response in Travellers Previously Vaccinated With MB-JEV
NCT01386827Phase 3Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2008
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, open-label trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE) (4 arms), sponsored by Helsinki University Hospital. Primary endpoint: Antibody titers 1 month after last vaccine dose. Started Jan 2008; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01386827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386827.